April Regulatory Update

Here is our monthly regulatory update. See below for changes from several states introducing legislation. A big thanks to our compliance team, who monitors state, federal, and international updates. 

The Fair Credit Reporting Act summary of rights: 

On March 20th, the Consumer Financial Protection Bureau (CFPB) updated the FCRA Summary of Consumer Rights. There were no substantive changes to the consumer rights. The Bureau updated the contact information for federal agencies listed in the document and corrected some minor errors. Businesses have until March 20, 2024 to fully implement the new version of the document, but are encouraged to begin using it as soon as possible.

FCRA summary of rights update

Model forms and disclosures

National Council of State Boards of Nursing (NCSBN):

On April 1, 2023, NCSBN launched the Next Generation NCLEX Examination, an enhancement of the world’s premier licensure exam. At the core of this enhanced exam is the NCSBN Clinical Judgment Measurement Model (NCJMM), which is a framework for the valid measurement of clinical judgment and decision making within the context of a standardized, high-stakes examination.

Next Generation NCLEX Examination 

California: 

Board of Nursing: 

The CA Board of Registered Nursing has issued a notice that Controlled Substance Utilization Review and Evaluation System (CURES) annual fee will decrease from $11 to $9 for licenses expiring on and after July 1, 2023. For more information visit CURES.

CA Board of Nursing CURES memo.

California Fair Employment and Housing Act: Fair Chance Act of 2023, conviction history: SB-809 has been introduced to the California Senate on 02/17/2023, and has been set for hearing in committee on 04/11/2023. This bill is intended to revise, recast, and expand the Fair Chance Act of 2023. It addresses how arrest and conviction records can be used in a background check to prevent discrimination based on arrest or conviction history in the employment process. 

California SB-809

Iowa:

ARC 6906C has been published as a Notice of Intended Action to amend Chapter 10, “Controlled Substances.” The proposed amendment would authorize the board, on a case-by-case basis, to issue a Controlled Substance Act Registration to a business location when it would be impractical to require each individual practitioner who administers or dispenses controlled substances to separately register at the business location. Examples of such business locations include, but are not limited to, ambulatory surgical centers, dialysis centers, federally qualified health centers, and standalone clinics associated with a hospital system.

ARC 6906C

The Iowa Board of Pharmacy adopted ARC 6953C on February 28, 2023. It will be effective on April 26, 2023. Under this rule, registered nurses are no longer required to gain additional licensure as a pharmacy technician to administer immunizations or vaccinations pursuant to a pharmacist’s order. Additional updates were made to the administration of specific medications and prescriptions. 

ARC 6953C 

Maryland:

Hospital Credentialing – Reappointment Process for Physician Staff – Modification: The credential reappointment process for physician staff included in certain minimum standards for hospitals licensed in the State be conducted in accordance with standards of the accreditation body that accredits a hospital, rather than every 2 years.

H.B. 633

Pennsylvania:

Introduced legislation: Increasing our Home Care Workforce

A bill intended to increase health care workforce numbers has been proposed to amending the act of July 19, 1979 (P.L.130, No.48), known as the Health Care Facilities Act. This act would alter the requirement of in-person interviews for employment of health-care workers. And would allow the face-to-face requirement to be fulfilled through the use of two-way video or other remote technology. 

HB-155

Disclaimer: This information has been gathered from a variety of sources. Although Verisys has made every effort to provide complete, accurate and up-to-date information, Verisys makes no warranties, express or implied, or representations as to the accuracy or reliability of this information. The information is fluid and evolving. Verisys assumes no liability or responsibility for any errors or omissions in the information contained in this resource.

The information contained in this newsletter comprises relevant information that we have found in the last month. It may not constitute a complete list of every regulation instituted by every board during the last month.